Find A Clinical Trial

Disease Type: Basket Trials

Trial ID USOR 21242
Sponsor ID CBP-21-0

A Phase 2 Multicenter, Randomized, Parallel Group Study to Establish the Efficacy and Safety of Combinations of CBP501, Cisplatin, and Nivolumab for > or = 3rd Line Treatment of Patients with Exocrine Pancreatic Cancer and WBC <10,000 at Screening

Principal Investigator
Keeran R. Sampat, MD
5 Locations
Trial ID AVB500-PC-005
Sponsor ID Aravive, Inc

A Phase 1b/2 Randomized Study of AVB-S6-500 plus Nabpaclitaxel and Gemcitabine in Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma